NEW YORK (GenomeWeb) – OpGen reported after the close of the market on Thursday an 18 percent increase in its third quarter revenues.

For the three months ended Sept. 30, the Gaithersburg, Maryland-based microbial genetics testing and analysis firm reported $980,786 in revenues, up from $834,824 for the same quarter a year ago.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A company hopes to capture the genetic diversity in India to power tailored therapeutics, BBC News reports.

Researchers tie variants in seven genes to insomnia risk, Live Science reports.

The US Environmental Protection Agency has approved an RNAi-based insecticide, according to the Atlantic.

In PLOS this week: locus near OAS1 linked to Sjogren's syndrome, rotavirus reassortment events uncovered by sequencing, and more.